Table 1 |
|||
|
A comparison of baseline socioeconomic and clinical characteristics of Aboriginal and non-Aboriginal participants |
|||
| Variable |
Aboriginal |
Not Aboriginal |
P-value |
|
|
|||
| (n = 88) |
(n = 534) |
||
| Year of initiation of therapy, no. (%) |
|||
| 1996 |
8 (9) |
79 (15) |
0.0588 |
| 1997 |
32 (36) |
225 (42) |
|
| 1998 |
21 (24) |
129 (24) |
|
| 1999 |
27 (31) |
101 (19) |
|
| Gender, no. (%) |
|||
| Female |
13 (15) |
49 (9) |
0.1044 |
| Male |
75 (85) |
485 (91) |
|
| Age |
|||
| Median |
37 |
38 |
0.9669 |
| Interquartile range |
33 – 45 |
33 – 44 |
|
| AIDS diagnosis, no. (%) |
|||
| Yes |
8 (9) |
99 (19) |
0.0296 |
| No |
80 (91) |
435 (81) |
|
| Protease inhibitor use |
|||
| Yes |
59 (67) |
418 (78) |
0.0209 |
| No |
29 (33) |
116 (22) |
|
| Baseline CD4 cell count (cells/mm3) |
|||
| Median |
275 |
260 |
0.6551 |
| Interquartile range |
150 – 425 |
110 – 410 |
|
| Baseline plasma HIV viral load (copies/ml) |
|||
| Median |
89,350 |
140,000 |
< 0.001 |
| Interquartile range |
21, 750 – 185,000 |
45,000 – 340, 000 |
|
| Adherence (<95%), no. (%) |
|||
| Yes |
58 (66) |
381 (71) |
0.2995 |
| No |
30 (34) |
153 (29) |
|
| HIV physician experience |
|||
| Median |
29 |
60 |
0.0133 |
| Interquartile range |
3 – 116 |
6 – 166 |
|
| History of IDU, no. (%) |
|||
| Yes |
52 (59) |
161 (30) |
< 0.001 |
| No |
36 (41) |
373 (70) |
|
| Completed high-school, no. (%) |
|||
| Yes |
38 (43) |
298 (56) |
0.0046 |
| No |
43 (49) |
171 (32) |
|
| Missing |
7 (8) |
65 (12) |
|
| Income, no. (%) |
|||
| < $10,000 |
49 (58) |
211 (43) |
0.0115 |
| >= $10,000 |
36 (42) |
281 (57) |
|
| Missing |
3 (3) |
42 (8) |
|
Lima et al. AIDS Research and Therapy 2006 3:14 doi:10.1186/1742-6405-3-14 |
|||
